Title: Weight Loss Medication Effectiveness Impacted by Various Factors, Says Expert
According to Dr. Meghan Garcia-Webb, the non-response to weight loss medications can be influenced by multiple factors. A recent clinical trial conducted in 2021 revealed that 13.8% of participants did not experience clinically significant weight loss while taking semaglutide, a GLP-1 medication.
GLP-1 medications like Ozempic and Wegovy have been praised as game-changers for individuals struggling with obesity and overweight. However, Dr. Garcia-Webb emphasizes that lifestyle changes, such as diet modifications, regular exercise, stress management, substance avoidance, and fostering positive social relationships, are crucial for achieving successful weight loss outcomes.
It is essential for individuals to take weight loss medications as prescribed to ensure optimal results. Consistency and the duration of treatment play a significant role in the success of these medications. Unfortunately, some individuals may face challenges in affording long-term use of drugs like Wegovy due to high costs and lack of insurance coverage.
Various factors, such as side effects, medical issues like hypothyroidism or eating disorders, insulin resistance in diabetic patients, and medication interference, can impact the effectiveness of weight loss drugs. For instance, patients taking other medications that promote weight gain may experience difficulties in achieving weight loss goals while using GLP-1 medications.
Dr. Garcia-Webb advises individuals to consult with their healthcare providers to address any concerns or issues that may be affecting their weight loss journey. By taking a comprehensive approach that includes medication adherence, lifestyle modifications, and addressing underlying health issues, individuals can increase their chances of successful weight loss.